| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4324855
[patent_doc_number] => 06312727
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Delivery of nucleic acid materials'
[patent_app_type] => 1
[patent_app_number] => 9/306568
[patent_app_country] => US
[patent_app_date] => 1999-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 18269
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/312/06312727.pdf
[firstpage_image] =>[orig_patent_app_number] => 306568
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/306568 | Delivery of nucleic acid materials | May 5, 1999 | Issued |
| 09/297353 | METHODS FOR PREPARING ARRAYS OF SINGLE-STRANDED DNA | Apr 29, 1999 | Abandoned |
Array
(
[id] => 4177397
[patent_doc_number] => 06159443
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'X-ray guided drug delivery'
[patent_app_type] => 1
[patent_app_number] => 9/302456
[patent_app_country] => US
[patent_app_date] => 1999-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23083
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/159/06159443.pdf
[firstpage_image] =>[orig_patent_app_number] => 302456
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/302456 | X-ray guided drug delivery | Apr 28, 1999 | Issued |
Array
(
[id] => 1323475
[patent_doc_number] => 06602684
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-05
[patent_title] => 'Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity'
[patent_app_type] => B1
[patent_app_number] => 09/294584
[patent_app_country] => US
[patent_app_date] => 1999-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 22
[patent_no_of_words] => 18159
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/602/06602684.pdf
[firstpage_image] =>[orig_patent_app_number] => 09294584
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/294584 | Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity | Apr 19, 1999 | Issued |
Array
(
[id] => 1505947
[patent_doc_number] => 06440409
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Method for efficient and highly selective control of microorganisms'
[patent_app_type] => B1
[patent_app_number] => 09/293549
[patent_app_country] => US
[patent_app_date] => 1999-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 11955
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/440/06440409.pdf
[firstpage_image] =>[orig_patent_app_number] => 09293549
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/293549 | Method for efficient and highly selective control of microorganisms | Apr 15, 1999 | Issued |
Array
(
[id] => 4092897
[patent_doc_number] => 06096505
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-01
[patent_title] => 'Noncloning technique for expressing a gene of interest'
[patent_app_type] => 1
[patent_app_number] => 9/290449
[patent_app_country] => US
[patent_app_date] => 1999-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 10867
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/096/06096505.pdf
[firstpage_image] =>[orig_patent_app_number] => 290449
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/290449 | Noncloning technique for expressing a gene of interest | Apr 12, 1999 | Issued |
Array
(
[id] => 4348377
[patent_doc_number] => 06291170
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Multi-genes expression profile'
[patent_app_type] => 1
[patent_app_number] => 9/286533
[patent_app_country] => US
[patent_app_date] => 1999-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9425
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291170.pdf
[firstpage_image] =>[orig_patent_app_number] => 286533
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/286533 | Multi-genes expression profile | Apr 4, 1999 | Issued |
Array
(
[id] => 4352531
[patent_doc_number] => 06214982
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Ribonuclease resistant RNA preparation and utilization'
[patent_app_type] => 1
[patent_app_number] => 9/282054
[patent_app_country] => US
[patent_app_date] => 1999-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 27425
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214982.pdf
[firstpage_image] =>[orig_patent_app_number] => 282054
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/282054 | Ribonuclease resistant RNA preparation and utilization | Mar 29, 1999 | Issued |
| 09/272904 | CELLULAR AND ANIMAL MODELS FOR DISEASES ASSOCIATED WITH MITOCHONDRIAL DEFECTS | Mar 18, 1999 | Abandoned |
Array
(
[id] => 1560802
[patent_doc_number] => 06437109
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => 'System for in vitro transposition'
[patent_app_type] => B1
[patent_app_number] => 09/272432
[patent_app_country] => US
[patent_app_date] => 1999-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17123
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/437/06437109.pdf
[firstpage_image] =>[orig_patent_app_number] => 09272432
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/272432 | System for in vitro transposition | Mar 18, 1999 | Issued |
Array
(
[id] => 1280218
[patent_doc_number] => 06641996
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => 'Microbial -glucuronidase genes, gene products and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/270957
[patent_app_country] => US
[patent_app_date] => 1999-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 34288
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/641/06641996.pdf
[firstpage_image] =>[orig_patent_app_number] => 09270957
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/270957 | Microbial -glucuronidase genes, gene products and uses thereof | Mar 16, 1999 | Issued |
Array
(
[id] => 4233847
[patent_doc_number] => 06143501
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-07
[patent_title] => 'Artificial tissues, methods for the production and the use thereof'
[patent_app_type] => 1
[patent_app_number] => 9/268894
[patent_app_country] => US
[patent_app_date] => 1999-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2569
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/143/06143501.pdf
[firstpage_image] =>[orig_patent_app_number] => 268894
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/268894 | Artificial tissues, methods for the production and the use thereof | Mar 15, 1999 | Issued |
| 09/171469 | VIRUS-LIKE PARTICLE | Feb 16, 1999 | Abandoned |
| 09/251686 | FORMS OF PROSTATE SPECIFIC ANTIGEN AND METHODS FOR THEIR DETECTION | Feb 16, 1999 | Abandoned |
| 09/249402 | TARGETED GENE DELIVERY TO CELLS BY FILAMENTOUS BACTERIOPHAGE | Feb 11, 1999 | Abandoned |
Array
(
[id] => 4235348
[patent_doc_number] => 06090562
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-18
[patent_title] => 'Recombinant clone selection system'
[patent_app_type] => 1
[patent_app_number] => 9/241592
[patent_app_country] => US
[patent_app_date] => 1999-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9431
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/090/06090562.pdf
[firstpage_image] =>[orig_patent_app_number] => 241592
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/241592 | Recombinant clone selection system | Feb 1, 1999 | Issued |
Array
(
[id] => 3929030
[patent_doc_number] => 05972370
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => 'Peptide/protein suspending formulations'
[patent_app_type] => 1
[patent_app_number] => 9/238159
[patent_app_country] => US
[patent_app_date] => 1999-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3258
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/972/05972370.pdf
[firstpage_image] =>[orig_patent_app_number] => 238159
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/238159 | Peptide/protein suspending formulations | Jan 27, 1999 | Issued |
Array
(
[id] => 4234710
[patent_doc_number] => 06143557
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-07
[patent_title] => 'Recombination cloning using engineered recombination sites'
[patent_app_type] => 1
[patent_app_number] => 9/233493
[patent_app_country] => US
[patent_app_date] => 1999-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 17862
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/143/06143557.pdf
[firstpage_image] =>[orig_patent_app_number] => 233493
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/233493 | Recombination cloning using engineered recombination sites | Jan 19, 1999 | Issued |
Array
(
[id] => 4403055
[patent_doc_number] => 06270969
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Recombinational cloning using engineered recombination sites'
[patent_app_type] => 1
[patent_app_number] => 9/233492
[patent_app_country] => US
[patent_app_date] => 1999-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 17988
[patent_no_of_claims] => 130
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/270/06270969.pdf
[firstpage_image] =>[orig_patent_app_number] => 233492
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/233492 | Recombinational cloning using engineered recombination sites | Jan 19, 1999 | Issued |
Array
(
[id] => 4151173
[patent_doc_number] => 06156309
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-05
[patent_title] => 'Insecticidal compositions and methods'
[patent_app_type] => 1
[patent_app_number] => 9/228861
[patent_app_country] => US
[patent_app_date] => 1999-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 20220
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/156/06156309.pdf
[firstpage_image] =>[orig_patent_app_number] => 228861
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/228861 | Insecticidal compositions and methods | Jan 11, 1999 | Issued |